lamivudine has been researched along with Tauopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ávila, J; Hernández, F; Vallés-Saiz, L | 1 |
1 other study(ies) available for lamivudine and Tauopathies
| Article | Year |
|---|---|
Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice.
Topics: Animals; Disease Models, Animal; HeLa Cells; Humans; Lamivudine; Mice; Mice, Transgenic; Reverse Transcriptase Inhibitors; tau Proteins; Tauopathies | 2023 |